| (ILA) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 347.00K | — |
| Operating expense | — | — |
| Net income | -1.77M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EVGN.TA returned -61.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -43.8% |
| 1 year | -61.5% |
| 5 years | -98.2% |
| 10 years | -99.3% |
| All-time high | ILA 68,150.00 (Dec 2013) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ILA1,000 in EVGN.TA would be worth today ›No. Evogene Ltd. has not paid a dividend in the past 12 months.
Evogene Ltd. is part of the Healthcare sector.
Evogene Ltd. has a market cap of 26.69M ILA, based on the latest quote.
Evogene Ltd. is expected to report earnings around Nov 19, 2026. That date is an estimate and has not been confirmed by the company.